In vivo xenograft mouse models demonstrated that KGM reverses 5-FU resistance in HCC tumors by inhibiting TLR4 to increase ER stress and activate PERK/ATF/CHOP signaling. Here, DDIT3 is linked to hepatocellular carcinoma.